Evidence map›Paper›PMID 24710340›Full record

ArticleJournal of biomolecular screening2014

Automated Structure-Activity Relationship Mining: Connecting Chemical Structure to Biological Profiles.

Mathias J Wawer, David E Jaramillo, Vlado Dančík, Daniel M Fass, Stephen J Haggarty, Alykhan F Shamji, Bridget K Wagner, Stuart L Schreiber, Paul A Clemons

Abstract read
In one paragraph

Article in Journal of biomolecular screening, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. DNA Barcoding a Complete Matrix of Stereoisomeric Small Molecules.Journal of the American Chemical Society · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mathias J WawerCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA.
David E JaramilloCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA.
Vlado DančíkCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA Mathematical Institute of the Slovak Academy of Sciences, Košice, Slovakia (on leave).
Daniel M FassCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA Chemical Neurobiology Laboratory, Center for Human Genetic Research, Massachusetts General Hospital, Departments of Neurology and Psychiatry, Harvard Medical School, Boston, MA, USA.
Stephen J HaggartyCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA Chemical Neurobiology Laboratory, Center for Human Genetic Research, Massachusetts General Hospital, Departments of Neurology and Psychiatry, Harvard Medical School, Boston, MA, USA.
Alykhan F ShamjiCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA.
Bridget K WagnerCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA.
Stuart L SchreiberCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA.
Paul A ClemonsCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA, USA pclemons@broadinstitute.org.

Funding

User Driven ProjectU54HG005032 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SCHREIBER, STUART L · 2008 to 2013
$88.1M
The Incubator ProjectP50GM069721 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SCHREIBER, STUART L · 2003 to 2012
$21.3M
Small-molecule probes of chromatin-mediated neuroplasticityR01DA028301 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HAGGARTY, STEPHEN J · 2009 to 2013
$3.0M
NHGRI NIH HHS U54 HG005032NHGRI NIH HHS U54-HG005032NIDA NIH HHS R01 DA028301NIDA NIH HHS R01DA028301NIGMS NIH HHS P50 GM069721NIGMS NIH HHS P50-GM069721
6 · The paper itself

Abstract

Understanding the structure-activity relationships (SARs) of small molecules is important for developing probes and novel therapeutic agents in chemical biology and drug discovery. Increasingly, multiplexed small-molecule profiling assays allow simultaneous measurement of many biological response parameters for the same compound (e.g., expression levels for many genes or binding constants against many proteins). Although such methods promise to capture SARs with high granularity, few computational methods are available to support SAR analyses of high-dimensional compound activity profiles. Many of these methods are not generally applicable or reduce the activity space to scalar summary statistics before establishing SARs. In this article, we present a versatile computational method that automatically extracts interpretable SAR rules from high-dimensional profiling data. The rules connect chemical structural features of compounds to patterns in their biological activity profiles. We applied our method to data from novel cell-based gene-expression and imaging assays collected on more than 30,000 small molecules. Based on the rules identified for this data set, we prioritized groups of compounds for further study, including a novel set of putative histone deacetylase inhibitors.

Indexed as

Structure-Activity RelationshipAutomationChemistry, PharmaceuticalCluster AnalysisComputational BiologyData MiningDrug DiscoveryGene Expression ProfilingGene Expression RegulationHistone Deacetylase InhibitorsHumansSoftwareHistone Deacetylase Inhibitorsassociation-rule miningfrequent-itemset mininghigh-content screeningsmall-molecule profilingstructure–activity relationships

Identifiers

PMID24710340
PMCPMC5554950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.